Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-MY-115310-2   |   PDF   |   Print   |  
| 
published: 12 Dec 2019 last updated: 17 May 2022
General Information
RISK ASSESSMENT REPORT OF THE GENETIC MODIFICATION ADVISORY COMMITTEE (GMAC) FOR AN APPLICATION FOR APPROVAL FOR CONFINED FIELD EVALUATION OF TRANSGENIC EKSOTIKA PAPAYA AGAINST PAPAYA DIEBACK DISEASE
EN
01 Aug 2019
Risk assessment details
  • Papaya modified for resistance to Papaya Dieback Disease
    | Malaysian Agricultural Research and Development Institute(MARDI) | Resistance to antibiotics (Kanamycin), Resistance to diseases and pests (Bacteria), Resistance to Gram-negative bacteria, Selectable marker genes and reporter genes
Methodology and points to consider
Please refer to the Risk Assessment Report
EN
Please refer to the Risk Assessment Report
EN
Please refer to the Risk Assessment Report
EN
Please refer to the Risk Assessment Report
EN
GMAC has conducted a thorough evaluation of the application for approval entitled ‘Confined Field Evaluation of Transgenic Eksotika Papaya against papaya dieback disease’ and has determined that the confined field trial does not endanger biological diversity or human, animal and plant health. GMAC recommends that the proposed application for confined field evaluation be APPROVED WITH TERMS AND CONDITIONS as listed in section IV (Proposed Terms and Conditions for Certificate of Approval). GMAC also recommends that Section VI (Identification of Issues to be addressed for future releases) be forwarded to the applicant for further reference.
EN
EN
Please refer to the Risk Assessment Report
EN
EN
Information sharing with other databases
No
Additional information
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1